Treatment of Esophageal Candidiasis

Clinical Presentation and Diagnosis

• The presence of oropharyngeal/laryngeal candidiasis combined with odynophagia is highly predictive of esophageal candidiasis, making empiric fluconazole therapy both clinically appropriate and cost-effective compared to endoscopic examination 1, 2, 3
• Odynophagia (painful swallowing) is a cardinal symptom of esophageal mucosal involvement 1, 2, 3

Recommended Treatment Regimen

• Fluconazole 200-400 mg daily (oral or IV) for 14-21 days is the first-line treatment 1, 2, 3, 4
• Oral fluconazole is preferred if the patient can tolerate oral intake 5

Management of Treatment Failure

• If symptoms persist after 7-14 days of fluconazole, escalate to itraconazole solution 200 mg daily or consider echinocandins 1, 2, 4
• Itraconazole solution 200 mg daily has a 64-80% response rate in fluconazole-refractory disease 1, 2, 4

Special Populations and Considerations

• Fluconazole remains first-line therapy for HIV/AIDS patients 1, 2, 5
• Initiate or optimize antiretroviral therapy (HAART) as adjunctive treatment to reduce recurrence rates 1, 2, 5
• Avoid fluconazole and other azoles in patients with prolonged QTc due to QTc prolongation risk 7
• Use echinocandins as first-line therapy in patients with prolonged QTc (micafungin, caspofungin, or anidulafungin) 7

Monitoring Response to Therapy

• Symptom improvement is expected within 48-72 hours 5
• If no improvement by 7 days, reassess diagnosis and consider endoscopy 1, 2
• Monitor liver function tests periodically if prolonged azole therapy (>21 days) is required 5